Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million

Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• XPeng stock falls on Q2 results miss; robotics arm raises $900 mln
• PMI and Altria strike cigarette contract manufacturing deal